All In Biotech

Free tool

FAERS Monitor: Vyalev

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216962 or its brand name (Vyalev, Foscarbidopa, Foslevodopa). Reports on generic versions are filed under their own applications.

Reports

8,815

Serious

7,502

85% of reports

Hospitalization

4,804

Death reported

1,446

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • on and off phenomenon1,211
  • fall1,137
  • hallucination892
  • death758
  • dyskinesia731
  • tremor513
  • device issue488
  • general physical health deterioration465
  • mobility decreased461
  • infusion site erythema430
  • malaise412
  • asthenia397
  • confusional state395
  • urinary tract infection378
  • gait disturbance367

Reports by year received

View as table
YearReports
20181
20231
2024380
20254,254
20264,179

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,344 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
on and off phenomenonSignal1,211665.3626.4627,813
infusion site erythemaSignal430128.2116.651,396
dyskinesiaSignal73143.740.729,956
hallucinationSignal89228.626.823,505
mobility decreasedSignal46115.414.16,176
device issueSignal48813.012.05,411
general physical health deteriorationSignal4659.68.83,590
fallSignal1,1378.27.77,244
tremorSignal5137.46.82,844
confusional stateSignal3955.85.31,590
urinary tract infectionSignal3785.34.81,321
gait disturbanceSignal3674.64.11,032
astheniaSignal3972.52.3369
malaiseSignal4122.22.0288
deathSignal7582.12.0454

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.